Transcriptomics Market PPT 2024: Size, Growth, Demand and Forecast till 2032
                     Global Transcriptomics 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A cc o r d i ng  t o  t h e  l a t e s t  r e po r t  b y  IM A R C  G r o up ,  t i t l e d  " T r a n s c r i p t o m i cs  Ma r k e t :  
G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  Gr o w th ,  O p p o r t u n i t y  a n d  F o r e c as t  2 0 2 4 -
20 3 2 , "  t h e  g l o b a l  t r a n s c r i p t o m i c s  m a r k e t  s i z e  r ea c h e d  U S $  7 . 2  B i l l i o n  i n  2 0 2 3 .
Fac tors  A f fec t ing  the  Growth  o f  t he  T ranscr ip tomics  Indust ry :
Report Advancement s  in  Sequencing Technolog ies:R ec e n t  a d v an c e me n t s  i n  s e q u en c i n g  t e c hn o l o g i e s  a re  i m p e l l i n g  t h e  g ro w t h  o f  t h e  
ma r k e t .  T h e  i n t ro d u c t i o n  o f  n e x t - g e ne r a t i o n  s e q u e nc i n g  ( N GS )  i s  r e vo l u t i o n i z i n g  t h e  
Highlight and f i e l d ,  a l l o w i n g  f o r  h i g h - t h r o ug h p u t  an a l y s i s  o f  r i b o n u c l e i c  a c i d  ( R N A )  s e q ue n c e s  w i th  un p a r a l l e l e d  ac c u r ac y  an d  s p e e d .  T h es e  t e c h n o l o g i e s  e n a b l e  c o m pr e h e n s i ve  p r o f i l i n g  
o f  g e ne  e x p r e s s i o n ,  o f f e r i n g  d e t a i l ed  i n s i g h t s  i n t o  t he  f un c t i o na l  e l e me n t s  o f  t h e  
Description ge n o m e  a n d  th e i r  r eg u l a t o r y  m e ch a n i s ms .  
A dd i t i o n a l l y ,  t h e  d e c re a s i n g  c o s ts  o f  s e q u e nc i n g  ha v e  ma d e  t h es e  te c h n o l og i e s  m o r e  
ac c e s s i b l e  t o  a  b r o ad e r  ra n g e  o f  r e s ea r c h e rs  a nd  i ns t i t u t i o ns .  T h i s  d e m oc r a t i z a t i o n  o f  
ac c e s s  fa c i l i t a te s  a  r i s e  i n  t r a n s c r i p t o m i c s  s t u d i e s ,  s p an n i n g  d i v e r s e  a p p l i ca t i o n s  f r o m 
ba s i c  b i o l o g i c a l  r e s ea r c h  to  c l i n i ca l  d i a g no s t i c s  a n d  p e r s o na l i z e d  me d i c i n e .  A s  a  
r es u l t ,  t h e  c o n t i n u o u s  i n no v a t i o n  a n d  i mp r o v e me n t  i n  s eq u e n c i ng  t e c h n o l og i e s  p l a y  a  
c r u c i a l  r o l e  i n  ex p a n d i ng  t h e  c a p a b i l i t i e s  a n d  a p p l i c a t i o n s  o f  t r a ns c r i p t o m i c s .
Increas ing Focus on Personal ized  Medicine:
The  grow ing  emphas is  on  pe rsona l i zed  med ic ine  i s  o f fe r i ng  a  f avo rab le  marke t  
ou t l ook .  Pe rsona l i zed  med ic i ne  re l ies  on  unders tand ing  the  ind i v i dua l  gene t i c  and  
molecu la r  p ro f i l es  o f  pa t i en ts  to  t a i l o r  t r ea tment s  and  i n t e r ven t ions  m ore  
e f fec t i ve ly .  T ransc r ip tom ics  p rov ides  c r i t i ca l  i ns igh t s  in t o  gene  express ion  
pa t t e rns ,  a id ing  in  iden t i f y ing  b iomarke rs  fo r  d i sease  d iagnos is ,  p rognos is ,  and  
Report t herapeut i c  response .  
Th is  app roach  a l l ows  fo r  more  p rec ise  and  e f f ec t i ve  t rea tment  s t r a teg ies ,  
Highlight and reduc ing  adverse  e f f ec ts  and  improv ing  pa t ien t  ou tcomes .  Pharmaceu t i ca l  
compan ies  and  hea l thca re  p rov iders  a re  inc reas ing ly  adop t ing  t r ansc r i p t om ics  t o  
deve lop  and  imp lem en t  pe rsona l i zed  t rea tmen t  p lans .  Fu r the rmore ,  gove rnmen ta l  
Description and  p r i va te  f und ing  f o r  research  in  pe rsona l i zed  med ic ine  i s  i nc reas ing ,  
suppor t ing  t he  expans ion  and in teg ra t ion  o f  t ransc r i p tom ic  da t a  in to  c l i n i ca l  
p rac t i ce .
Ris ing Prevalence of  Chronic Diseases and Cancer:
The  r i s ing  p reva lence  o f  ch ron i c  d iseases  and cancer  i s  suppor t ing  t he  marke t  
g rowt h .  Chron ic  d i seases ,  such  as  d iabet es ,  ca rd iovascu la r  d i seases ,  and  
neurodegenera t i ve  d iso rders ,  a long  w i th  var ious  f o rms  o f  cancer ,  p resen t  
subs t an t ia l  cha l lenges  to  g loba l  hea l thca re  sys t ems .
Unders tand ing  the  mo lecu la r  mechan isms under l y ing  these  cond i t ions  is  
essen t ia l  f o r  deve lop ing  e f fec t i ve  t rea tments  and  p reven t ive  s t ra teg ies .  
T ranscr ip tomics  o f fe rs  va luab le  ins igh ts  in to  the  gene  express ion  changes  
assoc ia ted  w i th  d isease  s ta tes ,  enab l ing  the  iden t i f i ca t ion  o f  nove l  the rapeu t ic  
ta rge ts  and  b iomarke rs .  The  demand fo r  more  e f fec t ive  d iagnos t i c  t oo ls  and  
persona l ized  t rea tment  op t ions  d r ives  the  need  fo r  comprehens ive  
Report t ransc r ip tomic  ana lys is .
Highlight and Request  for  a  PDF sample  o f  th is  repor t :  h t tps : / /www. imarcgroup .com/ t ranscr ip tomics -marke t / reques tsamp le
Description
Report Description
Global  Transcriptomics Market  Trends:
The increas ing investment  in  genomic  research is  bo ls ter ing the market  growth.  Governments ,  pr ivate  
inst i tu t ions,  and heal thcare organizat ions recognize the potent ia l  o f  genomic  s tud ies  in  advanc ing medica l  
sc ience and improv ing heal th  outcomes.  Substant ia l  fund ing is  be ing a l located to  research pro jec ts  that  
u t i l i ze  t ranscr ip tomic technolog ies  to  exp lore gene expression pat terns and the i r  imp l icat ions in  heal th  and 
d isease.  
These investments  suppor t  the development  o f  innovat ive t ranscr ip tomic  too ls  and methodolog ies ,  
enhanc ing the ab i l i ty  to  conduct  large-sca le  and h igh-reso lu t ion s tud ies .  Fur thermore,  co l laborat ions 
between academic  ins t i tu t ions and b io tech companies are fos ter ing the in tegrat ion of  t ranscr ip tomics in to  
broader  genomic  research in i t ia t ives.  Th is  f inanc ia l  and co l laborat ive suppor t  acce lerates the d iscovery o f  
new b iomarkers ,  therapeut ic  targets,  and d iagnost ic  too ls ,  dr iv ing innovat ion wi th in  the market .
View Report  TOC,  F igures and Tables :  ht tps: / /www.imarcgroup.com/transcriptomics-market
Breakup by Type:
• Instruments
• Consumables
• Software
• Services
Report Breakup by Technology:
• Microarray
Segmentation • Real -Time Quantitat ive Polymerase Chain 
React ion (Q-PCR)
• Sequencing Technologies
Breakup by Application:
• Diagnost ics  and Disease Profi l ing
• Drug Discovery
• Others
Breakup by End User:
• Academic and Research Insti tutes
• Pharmaceutical  Companies
• Biotechnology Companies
• Others
Report 
Breakup by Region:
Segmentation • North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Agilent Technologies Inc.
• Becton Dickinson and Company
• BGI Group
• Bio-Rad Laboratories Inc.
Competitive • Biospyder Technologies Inc.
• I l lumina Inc.
Landscape 
• Nanostr ing Technologies Inc.
with Key • Qiagen
Players • Roche Holding AG
• Takara Bio Inc.
• Thermo Fisher Scient ifi c Inc.  
What was the size of the global transcriptomics market 
in 2023?
What is the expected growth rate of the global 
transcriptomics market during 2024-2032?
What are the key factors driving the global 
transcriptomics market?
Key 
What has been the impact of COVID-19 on the global 
Questions transcriptomics market?
Answered in What is the breakup of the global transcriptomics market based on type?
the Report What is the breakup of the global transcriptomics 
market based on the technology?
What is the breakup of the global transcriptomics 
market based on the application?
What are the key regions in the global transcriptomics 
market?
Who are the key players/companies in the global 
transcriptomics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  T r a n s c r i p t o m i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  T y p e
    6 . 1     I n s t r u m e n t s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     C o n s u m a b l e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S o f t w a r e
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     S e r v i c e s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7     M a r k e t  B r e a k u p  b y  T e c h n o lo g y
    7 . 1     M i c r o a r r a y
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     R e a l - T i m e  Qu a n t i t a t i v e  P o l y m e r a s e  C h a i n  R e a c t i o n  ( Q -
P C R )
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
Table of     7 . 3     S e q u e n c i n g  T e c h n o l o g i e s        7 . 3 . 1  M a r k e t  T r e n d s
        7 . 3 . 2  M a r k e t  F o r e c a s t
8     M a r k e t  B r e a k u p  b y  A p p l i c a t io n
Contents     8 . 1     D i a g n o s t i c s  a n d  D i s e a s e  P r o f i l i n g
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     D r u g  D i s c o v e r y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O th e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9     M a r k e t  B r e a k u p  b y  E n d  U s e r
    9 . 1     A c a d e m i c  a n d  R e s e a r c h  I n s t i t u t e s
        9 . 1 . 1  M a r k e t  T r e n d s
        9 . 1 . 2  M a r k e t  F o r e c a s t
F o r  m o r e  i n f o r m a t io n ,  v i s i t :  
ht tps : / /www. imarcgroup .com/ t ranscr ip tomics -marke t / t oc
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: